Market Size of Molecular Quality Controls Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | > 10.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Molecular Quality Controls Market Analysis
The molecular quality controls market studied was anticipated to grow with a CAGR of nearly 10.5% during the forecast period. The major factors attributing to the growth of the market are a rise in the global prevalence of infectious diseases, HIV, cancers which necessitate novel diagnostic methods for efficient treatment and quality controls to monitor their performance. For instance, according to the Joint United Nations Programme on HIV and AIDS (UNAIDS) report published in 2019, 24.5 million people with HIV were accessing antiretroviral therapy globally. Additionally, increased participation of the government to control the outbreaks of infectious diseases and a rise in the demand for quality assessment support along with immediate diagnosis systems are expected to contribute to the growth of the global market during the forecast period
Molecular Quality Controls Industry Segmentation
Molecular quality controls are used to evaluate the performance of molecular tests such as in vitro nucleic acid testing procedures for viral load assays, pathogen detection, leukocyte reduced apheresis platelet (LRAP) units, healthcare-associated infections (HAIs) like pneumonia, urinary tract infections and more. These products majorly focus on the detection of defects, quality control, and validation panels to support in the implementation and monitoring assay-kit lot performance for clinical and research laboratories, blood diagnostic centers, and IVD manufacturers.
| By Product Type | |
| Independent Control | |
| Instrument Specific-Control |
| By Application | |
| Oncology | |
| Genetic Testing | |
| Infectious Diseases | |
| Others |
| By End-users | |
| Hospitals | |
| Clinical Laboratories | |
| IVD Manufacturers & CROs | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Molecular Quality Controls Market Size Summary
The molecular quality controls market is poised for significant growth, driven by the increasing global prevalence of infectious diseases, HIV, and cancers, which demand innovative diagnostic methods and stringent quality controls. The market is characterized by the rising involvement of government initiatives to manage disease outbreaks and the growing need for quality assessment and rapid diagnostic systems. Independent controls are expected to dominate the market due to their precise and unbiased performance assessments, which are independent of instruments and reagents. This segment's growth is further supported by the increasing adoption of these controls among third-party independent quality assessments, attributed to their broad application range and cost-effectiveness.
Regionally, North America is anticipated to lead the molecular quality control market, supported by the high adoption of advanced diagnostic infrastructure and a growing number of accredited clinical laboratories. The United States, in particular, holds a significant market share due to its large patient pool and the prevalence of infectious diseases. The market is moderately competitive, with major players like Bio-Rad Laboratories Inc, F. Hoffmann-La Roche AG, and bioMerieux Inc actively expanding their market presence through strategic acquisitions and product innovations. The oncology segment generates the highest revenue, driven by the increasing focus on cancer research and personalized medicine, while genetic testing is expected to experience the fastest growth due to its expanding applications in genetic diagnosis and treatment.
Molecular Quality Controls Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increased Demand for Advanced Diagnostics for Sensitve Reports and Accurate Diagnosis
-
1.2.2 Rise Global Incidence of Infectious Diseases, Cancers and Genetic Disorders
-
1.2.3 Rise in the Volume of Accredited Clinical Laboratories and Adoption of Third-Party Quality Controls
-
-
1.3 Market Restraints
-
1.3.1 Complex Regulatory Framework by Authorities Delaying Approvals
-
1.3.2 Unfavorable Reimbursement Poilicies for Molecular Tests
-
1.3.3 Additional Costs Involved in Quality Control testing Resulting in Budget Constraints for Healthcare Providers
-
1.3.4 Lack of Stringent Regulations for Clinical Laboratory Accreditation in Several Emerging Economies
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Independent Control
-
2.1.2 Instrument Specific-Control
-
-
2.2 By Application
-
2.2.1 Oncology
-
2.2.2 Genetic Testing
-
2.2.3 Infectious Diseases
-
2.2.4 Others
-
-
2.3 By End-users
-
2.3.1 Hospitals
-
2.3.2 Clinical Laboratories
-
2.3.3 IVD Manufacturers & CROs
-
2.3.4 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Molecular Quality Controls Market Size FAQs
What is the current Molecular Quality Controls Market size?
The Molecular Quality Controls Market is projected to register a CAGR of greater than 10.5% during the forecast period (2024-2029)
Who are the key players in Molecular Quality Controls Market?
Bio-Rad Laboratories Inc, bioMerieux Inc, F. Hoffmann-La Roche AG, SeraCare Life Sciences Inc and ZeptoMetrix Corporation are the major companies operating in the Molecular Quality Controls Market.
